Posted inMedical Technology
Heartflow pumps up IPO plans to $300M
Heartflow has pumped up its IPO ambitions, raising its proposal into the vicinity of $300 million. After first setting up…
Posted inMedical Technology
Orchestra BioMed scores $111M, backed by Medtronic, Ligand
Orchestra BioMed reported that it has secured over $111 million in financing through a series of transactions and offerings—supported by…
Posted inMedical Technology
Alcon to buy struggling lensmaker Staar Surgical in $1.5B deal
Alcon is building out its portfolio of lens implants, with a $1.5 billion deal to acquire the flagging Staar Surgical…
Posted inMedical Technology
FDA formally kicks off medical device user fee negotiations
The FDA formally kicked off its quinquennial process to reauthorize the federal user fee legislation that helps fund its medical…
Posted inMedical Technology
Synchron links brain-computer interface to iPad through new Apple protocol
The brain-computer interface developer Synchron has shown that its minimally invasive device can help connect a patient with an iPad,…
Posted inMedical Technology
Ultromics nets $55M to boost its AI ultrasound software for detecting hidden heart failure
Ultromics has raised $55 million in venture capital funding to expand the reach of its artificial-intelligence-powered ultrasound diagnostics for hidden…
Posted inMedical Technology
Baxter cuts financial forecast while pausing infusion pump shipments
Baxter saw its stock price plunge by more than 20% after it lowered its revenue projections for the remainder of…
Posted inMedical Technology
Dexcom CEO Kevin Sayer to pass torch to COO Jake Leach
After taking on the title of president earlier this year, Dexcom’s Jake Leach will be stepping into the role of…
Posted inMedical Technology
Cardiosense scores FDA clearance for wearable sensor that monitors heart function
Medical AI company Cardiosense has claimed FDA clearance for its CardioTag device, a wearable sensor that provides a noninvasive approach…
Posted inMedical Technology
InBrain Neuroelectronics reports positive interim results from study of BCI tech
Barcelona-based InBrain Neuroelectronics shared interim findings from a first-in-human clinical study of its graphene-based brain-computer interface (BCI) technology. InBrain says…